Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8872 |
High Similarity |
NPD3027 |
Phase 3 |
0.8657 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.854 |
High Similarity |
NPD1613 |
Approved |
0.8248 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8129 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8058 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8043 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7984 |
Intermediate Similarity |
NPD228 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7962 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7883 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7883 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7883 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.781 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7792 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7786 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7762 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7704 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7692 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7692 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7677 |
Intermediate Similarity |
NPD37 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7589 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7481 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7467 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7439 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7421 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7403 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7397 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7296 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD940 |
Approved |
0.7287 |
Intermediate Similarity |
NPD846 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7267 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD7635 |
Approved |
0.725 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7235 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7229 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7192 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7168 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7164 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.716 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7113 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7107 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7092 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7092 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7068 |
Intermediate Similarity |
NPD968 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7047 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD943 |
Approved |
0.7047 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7044 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7032 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7027 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1651 |
Approved |
0.702 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD4538 |
Approved |
0.702 |
Intermediate Similarity |
NPD4536 |
Approved |
0.702 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7014 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7007 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.6994 |
Remote Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD6788 |
Approved |
0.6993 |
Remote Similarity |
NPD1091 |
Approved |
0.6986 |
Remote Similarity |
NPD4624 |
Approved |
0.6975 |
Remote Similarity |
NPD5929 |
Approved |
0.6974 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD3750 |
Approved |
0.6966 |
Remote Similarity |
NPD2922 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD1283 |
Approved |
0.6962 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6959 |
Remote Similarity |
NPD7240 |
Approved |
0.6957 |
Remote Similarity |
NPD1398 |
Phase 1 |
0.6947 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD2232 |
Approved |
0.6944 |
Remote Similarity |
NPD2233 |
Approved |
0.6944 |
Remote Similarity |
NPD2230 |
Approved |
0.6943 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6943 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6929 |
Remote Similarity |
NPD7340 |
Approved |
0.6923 |
Remote Similarity |
NPD5241 |
Discontinued |
0.6923 |
Remote Similarity |
NPD3496 |
Discontinued |
0.6919 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD7906 |
Approved |
0.6913 |
Remote Similarity |
NPD3144 |
Approved |
0.6913 |
Remote Similarity |
NPD3145 |
Approved |
0.6903 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6901 |
Remote Similarity |
NPD5691 |
Approved |
0.6899 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD844 |
Approved |
0.6899 |
Remote Similarity |
NPD2859 |
Approved |
0.6899 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD2860 |
Approved |
0.6894 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6889 |
Remote Similarity |
NPD290 |
Approved |
0.6887 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6886 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6886 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6884 |
Remote Similarity |
NPD5535 |
Approved |
0.6883 |
Remote Similarity |
NPD5762 |
Approved |
0.6883 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD5763 |
Approved |
0.6875 |
Remote Similarity |
NPD3092 |
Approved |
0.6871
|
Remote Similarity |
NPD2977 |
Approved |